Biotech | April 07, 2022
Covestro and PharmaJet work to take the sting out of vaccinations
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status
U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
Subscribe To Our Newsletter & Stay Updated
